Verily Life Sciences
Benjamin W. Nelson, Ph.D., is a prominent Senior Clinical Research Scientist specializing in digital biomarkers at Verily since 2022, with concurrent roles as Clinical Science Lead for Mental and Behavioral Health at Harvard Medical School and as an Adjunct Professor. Nelson's extensive background includes significant positions at Meru Health, University of North Carolina at Chapel Hill, and the Oregon Research Institute, where work focused on the integration of ethical research, data science, and clinical efficacy in the realm of mental health. Academic credentials include a PhD and MS in Clinical Psychology from the University of Oregon, along with a Clinical Psychology Residency at the University of Washington. Nelson has also demonstrated a robust teaching portfolio, holding multiple instructional roles in psychology courses throughout graduate education.
This person is not in any offices
Verily Life Sciences
45 followers
Verily's mission is to make the world’s health data useful so that people enjoy longer and healthier lives. The company was launched in 2015 and is a subsidiary of Alphabet.